Esketamine is the S-enantiomer of the non-steroidal N-methylphenylcyclohexanone derivative ketamine, a dissociative anesthetic utilized as a targeted treatment for treatment-resistant depression. By modulating… Read more
Esketamine is the S-enantiomer of the non-steroidal N-methylphenylcyclohexanone derivative ketamine, a dissociative anesthetic utilized as a targeted treatment for treatment-resistant depression. By modulating glutamate transmission within the central nervous system, this agent provides rapid therapeutic relief for patients with major depressive disorder who are unresponsive to conventional antidepressants. Our collection of Esketamine reference standards, including identified degradation products and related manufacturing impurities, is essential for pharmaceutical laboratories conducting rigorous impurity profiling and quality control. Chemists and analysts rely on these high-quality materials to develop, validate, and verify analytical methods, ensuring the purity and stability of the active pharmaceutical ingredient. These compounds support critical regulatory compliance processes, enabling accurate identification and quantification of impurities during the development of pharmaceutical formulations and throughout the production lifecycle.